greeksoup/ stock research

Merck (MRK) FY2022 results: revenue $59.3 billion, up 21.7% on the year

Merck & Co., Inc. (MRK) reported revenue of $59.3 billion for fiscal 2022, the year ended 31 December 2022, up 21.7% on the year before. Net income was $14.5 billion, up 11.3%, and diluted earnings per share $5.71. The figures are the company's own, from the 10-K it filed with the SEC on 24 February 2023.

Revenue
$59.3 billion
+21.7% on the year
FY2015FY2022
Operating margin
n/a
FY2015FY2022
Net income
$14.5 billion
+11.3% on the year
FY2015FY2022
Diluted EPS
$5.71
+11.1% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue59,28348,70441,518+21.7%
Cost of revenue17,41113,62613,618+27.8%
Gross profit41,87235,07827,900+19.4%
Gross margin70.6%72.0%67.2%
Research and development13,54812,24513,397+10.6%
Selling, general and administrative10,0429,6348,955+4.2%
Interest expense962806831+19.4%
Pre-tax income16,44413,8795,863+18.5%
Income tax1,9181,5211,340+26.1%
Effective tax rate11.7%11.0%22.9%
Net income14,51913,0497,067+11.3%
Net margin24.5%26.8%17.0%
Diluted EPS$5.71$5.14$2.78+11.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow19,09514,10910,253+35.3%
Capital expenditure4,3884,4484,429-1.3%
Free cash flow14,7079,6615,824+52.2%
Free cash flow margin24.8%19.8%14.0%
Cash from investing-4,960n/a-9,443
Cash from financing-9,119n/a-2,832
Depreciation and amortisation3,9243,1783,469+23.5%
Share-based compensation541479441+12.9%
Buybacks0.08401,281
Dividends paid7,0126,6106,215+6.1%
Dividend per share$2.80$2.64$2.48+6.1%
Diluted shares, weighted2,542m2,538m2,541m+0.2%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity45,99138,18425,317+20.4%
Non-controlling interest67.073.087.0-8.2%
Debt30,70033,10031,800-7.3%
Operating lease liabilities1,0131,2251,335-17.3%
Other liabilities31,38933,11233,049-5.2%
Total liabilities and equity109,160105,69491,588+3.3%
Fixed assets21,42219,27917,000+11.1%
Goodwill21,20421,26418,882-0.3%
Intangible assets20,26922,93314,101-11.6%
Investments1,513370785+308.9%
Cash and equivalents12,6948,0968,062+56.8%
Receivables9,4509,2306,803+2.4%
Inventory5,9115,9535,554-0.7%
Other assets16,69718,56920,401-10.1%
Total assets109,160105,69491,588+3.3%

10-K for the year ended 31 December 2022, filed 24 February 2023: the filing.